Radiographic progression with nonrising PSA in metastatic castration-resistant prostate cancer: post hoc analysis of PREVAIL

BACKGROUND: Advanced prostate cancer is a phenotypically diverse disease that evolves through multiple clinical courses. PSA level is the most widely used parameter for disease monitoring, but it has well-recognized limitations. Unlike in clinical trials, in practice, clinicians may rely on PSA moni...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Prostate Cancer Prostatic Dis
Autori principali: Bryce, A H, Alumkal, J J, Armstrong, A, Higano, C S, Iversen, P, Sternberg, C N, Rathkopf, D, Loriot, Y, de Bono, J, Tombal, B, Abhyankar, S, Lin, P, Krivoshik, A, Phung, D, Beer, T M
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group 2017
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5435962/
https://ncbi.nlm.nih.gov/pubmed/28117385
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/pcan.2016.71
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi